Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unraveling Immune-Related lncRNAs in Breast Cancer Molecular Subtypes
Carolina Mathias, João C. D. Muzzi, Bruna Borba Antunes, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Current Molecular Combination Therapies Used for the Treatment of Breast Cancer
Yiling Wang, Audrey Minden
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11046-11046
Open Access | Times Cited: 66
The Role of lncRNA in the Development of Tumors, including Breast Cancer
Beata Smolarz, Anna Zadrożna-Nowak, Hanna Romanowicz
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8427-8427
Open Access | Times Cited: 48
The current advances of lncRNAs in breast cancer immunobiology research
Marco Antonio Fonseca-Montaño, Karla Itzel Vázquez-Santillán, Alfredo Hidalgo‐Miranda
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
SLC35A2-mediated bisected GlcNAc-modified extracellular vesicles enhance immune regulation in breast cancer lung metastasis
Yangyang Li, Tao Guo, Juntong He, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114505-114505
Closed Access
Comprehensive Analysis of Ferroptosis-Related LncRNAs in Breast Cancer Patients Reveals Prognostic Value and Relationship With Tumor Immune Microenvironment
Zhengjie Xu, Suxiao Jiang, Juan Ma, et al.
Frontiers in Surgery (2021) Vol. 8
Open Access | Times Cited: 24
New Advances in Targeted Therapy of HER2-Negative Breast Cancer
Junsha An, Cheng Peng, Xiaofang Xie, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
LncRNA EBLN3P attributes methotrexate resistance in osteosarcoma cells through miR-200a-3p/O-GlcNAc transferase pathway
Mingxia Sun, Haiyan An, Yan-Bin Sun, et al.
Journal of Orthopaedic Surgery and Research (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 17
MicroRNAs miR-142-5p, miR-150-5p, miR-320a-3p, and miR-4433b-5p in Serum and Tissue: Potential Biomarkers in Sporadic Breast Cancer
Tamyres Mingorance Carvalho, Guillermo Ortiz Brasil, Tayana Schultz Jucoski, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 15
Vitamin D, Th17 Lymphocytes, and Breast Cancer
Beata Filip‐Psurska, Honorata Zachary, Aleksandra Strzykalska, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3649-3649
Open Access | Times Cited: 15
LncRNA EBLN3P Facilitates Osteosarcoma Metastasis by Enhancing Annexin A3 mRNA Stability and Recruiting HuR
Shengtao Wang, Xinxin Zeng, Peng Gui, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 13, pp. 8690-8703
Open Access | Times Cited: 7
Long noncoding RNA endogenous bornavirus-like nucleoprotein acts as an oncogene by regulating microRNA-655-3p expression in T-cell acute lymphoblastic leukemia
Jinhua Yang, Yingying Yang
Bioengineered (2022) Vol. 13, Iss. 3, pp. 6409-6419
Open Access | Times Cited: 12
Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
Yujian Xu, Youbai Chen, Zehao Niu, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 12
Identification of gene signatures for COAD using feature selection and Bayesian network approaches
Yangyang Wang, Xiaoguang Gao, Xinxin Ru, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
The biological function of the long non-coding RNA endogenous born avirus-like nucleoprotein in lung adenocarcinoma is mediated through the microRNA-655-3p/B-cell lymphoma-2 axis
Xiaopeng Wang, Jing Yin
Bioengineered (2022) Vol. 13, Iss. 4, pp. 10679-10690
Open Access | Times Cited: 10
Long non-coding RNA signatures and related signaling pathway in T-cell acute lymphoblastic leukemia
Homayon Yousefi, Daryush Purrahman, Mohammad Jamshidi, et al.
Clinical & Translational Oncology (2022) Vol. 24, Iss. 11, pp. 2081-2089
Closed Access | Times Cited: 10
Feature selection approaches identify potential plasma metabolites in postmenopausal osteoporosis patients
Jihan Wang, Yangyang Wang, Yuhong Zeng, et al.
Metabolomics (2022) Vol. 18, Iss. 11
Closed Access | Times Cited: 10
By modulating miR‐525‐5p/Bax axis, LINC00659 promotes vascular endothelial cell apoptosis
Xizheng Zhu, Beijia Chen, Hui Xu
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Genome-wide screening and immune landscape suggest a potential-m6A-related lncRNA risk signature for predicting prognosis of melanoma
Kangjie Shen, Hongye Wang, Shengbai Xue, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 5, pp. 241-241
Open Access | Times Cited: 9
Long Non-Coding RNAs Associated with Ribosomes in Human Adipose-Derived Stem Cells: From RNAs to Microproteins
Bernardo Bonilauri, Fabíola Holetz, Bruno Dallagiovanna
Biomolecules (2021) Vol. 11, Iss. 11, pp. 1673-1673
Open Access | Times Cited: 11
DoxoDB: A Database for the Expression Analysis of Doxorubicin-Induced lncRNA Genes
Rebecca Distefano, Mirolyuba Ilieva, Jens Hedelund Madsen, et al.
Non-Coding RNA (2023) Vol. 9, Iss. 4, pp. 39-39
Open Access | Times Cited: 4
PD-1/PD-L1 Inhibitors Response in Triple-Negative Breast Cancer: Can Long Noncoding RNAs Be Associated?
Carolina Mathias, Vanessa Nascimento Kozak, Jessica Maria Magno, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4682-4682
Open Access | Times Cited: 4
FTO, PIK3CB serve as potential markers to complement CEA and CA15-3 for the diagnosis of breast cancer
Jintao Mi, Hongsheng Zhang, Weiwei Cao, et al.
Medicine (2023) Vol. 102, Iss. 42, pp. e35361-e35361
Open Access | Times Cited: 4
LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer
Marie‐Claire D. Wasson, Jaganathan Venkatesh, Hannah F. Cahill, et al.
Gene (2024) Vol. 901, pp. 148165-148165
Closed Access | Times Cited: 1
LncRNA MEG3 suppresses hepatocellular carcinoma by stimulating macrophage M1 polarization and modulating immune system via inhibiting CSF-1 in vivo/vitro studies
Jiajie Lin, Junling Huang, Chuan Tan, et al.
International Journal of Biological Macromolecules (2024) Vol. 281, pp. 136459-136459
Closed Access | Times Cited: 1
Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma
Wentao Lin, Zhou-yong Tan, Xi-chi Fang
SLAS TECHNOLOGY (2023) Vol. 29, Iss. 1, pp. 100101-100101
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top